MediLexicon Logo
MediLexicon Logo
Abbreviations        Abbrev Definitions        Dictionary        ICD Codes        Equipment        Hospitals        Drugs        More..

Effexor (venlafaxin HCL)

Company: Wyeth
Approval Status: Approved March 1999
Treatment for: Psychiatry/Psychology
Areas: Psychiatry / Psychiatric
Possible similar drugs: Effexor XR

| General Information | Side Effects | Mechanism of Action | Additional Information |

General Information

Effexor was approved for the treatment of depression in 1993. Effexor increases the levels of both serotonin and norepinephrine (two neurotransmitters though to cause the symptoms of depression) in the brain.

Effexor's latest approval is for the treatment of anxiety disorder. It is estimated that 95% of people with depression experience at least one symptom of anxiety, including excessive or uncontrollable worry, apprehension, irritability, and muscle tension. Studies suggest that co-morbid depression and anxiety may have an impact on a patient's social functioning and is associated with a 30% to 60% increase in the utilization of healthcare services.

Side Effects

Some of the side effects of Effexor include the following:

  • headache
  • nausea
  • weight loss
  • constipation
  • blurry vision
  • diarrhea
  • dizziness
  • dry mouth
  • increased blood pressure

Mechanism of Action

Effexor affects various neuro chemicals in the body which are responsible for nervous system regulation. It inhibits specifically norepinephrine and serotonin reuptake, and also weakly inhibits dopamine reuptake. The net result is more neuro chemicals circulating in the nervous system.

Additional Information

Pregnancy and Breastfeeding Issues

If you are pregnant, plan to become pregnant, or breastfeeding, discuss the potential risks of this or any medication with your doctor.

It is also recommended that you talk to your doctor about Effexor if you have: high blood pressure, heart, liver, or kidney disease.

< back to top

Effexor Drug Information

The Effexor drug information shown above is licensed from Thomson CenterWatch. The information provided here is for general educational purposes only and does not constitute medical or pharmaceutical advice which should be sought from qualified medical and pharmaceutical advisers.

MediLexicon International Ltd Logo

Privacy Policy   |    Disclaimer   |    Contact / Feedback

MediLexicon International Ltd
Bexhill-on-Sea, UK
MediLexicon International Ltd © 2004-2016 All rights reserved.